Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00220220
What this trial is testing

Amlodipine as add-on to Olmesartan in Hypertension

Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 429
Large-scale testing (Phase 3)Study completedNCT00430508
What this trial is testing

Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 972
Large-scale testing (Phase 3)Study completedNCT00902538
What this trial is testing

Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 2,204
Early research (Phase 1)Ended earlyNCT01934647
What this trial is testing

Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 7
Post-approval studies (Phase 4)Study completedNCT00670566
What this trial is testing

Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients

Who this might be right for
Hypertension
Sanofi 503
Early research (Phase 1)Looking for participantsNCT07483372
What this trial is testing

Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease

Who this might be right for
Resistant Arterial HypertensionChronic Kidney Disease (Stage 3-4)
The First Affiliated Hospital with Nanjing Medical University 3
Early research (Phase 1)Study completedNCT03744637
What this trial is testing

Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 25
Large-scale testing (Phase 3)Study completedNCT00765674
What this trial is testing

Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension

Who this might be right for
Hypertension
Novartis 1,191
Large-scale testing (Phase 3)Study completedNCT01204398
What this trial is testing

Telmisartan+Amlodipine Fixed Dose Combination in Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 27
Large-scale testing (Phase 3)Study completedNCT00242346
What this trial is testing

High Doses of Candesartan Cilexetil on the Reduction of Proteinuria

Who this might be right for
Proteinuria
AstraZeneca 270
Not applicableStudy completedNCT02863510
What this trial is testing

Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney Disease

Who this might be right for
HypertensionChronic Kidney Disease
Heart of England NHS Trust 10
Post-approval studies (Phase 4)Study completedNCT02178306
What this trial is testing

Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis

Who this might be right for
Hypertension
Boehringer Ingelheim 82
Large-scale testing (Phase 3)Not Yet RecruitingNCT06716970
What this trial is testing

QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension

Who this might be right for
Essential Hypertension
Wuhan Createrna Science and Technology Co., Ltd 810
Testing effectiveness (Phase 2)Study completedNCT03574363
What this trial is testing

Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseasesHypertension
KBP Biosciences 162
Large-scale testing (Phase 3)Study completedNCT00327587
What this trial is testing

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Who this might be right for
Hypertension
Novartis 2,279
Large-scale testing (Phase 3)Looking for participantsNCT05732727
What this trial is testing

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease(CKD)Uncontrolled Hypertension
University Hospital, Tours 720
Post-approval studies (Phase 4)Study completedNCT02853045
What this trial is testing

Comparison of Blood Pressure Control Achieved in Antihypertensive or Generic Drugs in Moderate to Severe Hypertensive Patients

Who this might be right for
Hypertension
Centre Hospitalier Universitaire de Saint Etienne 50
Large-scale testing (Phase 3)Study completedNCT00847626
What this trial is testing

Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension

Who this might be right for
Hypertension
Takeda 1,711
Large-scale testing (Phase 3)Ended earlyNCT04968184
What this trial is testing

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Diseases
KBP Biosciences 652
Not applicableActive Not RecruitingNCT01047735
What this trial is testing

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObesity
University of Pittsburgh 69
Next Page